Nevertheless, our current study firstly demonstrated the impact of TGF-β1 signaling on metformin’s regulation of blood glucose and might provide a preclinical test for improving metformin resistance for glycemic control in patients with type 2 diabetes. The gene discussed is TGFB1; the disease is type 2 diabetes mellitus.